IGC Pharma Inc Share Price Today: Live Updates & Key Insights

IGC Pharma Inc share price today is $0.2862, up 5.22%. The stock opened at $0.2706 against the previous close of $0.272, with an intraday high of $0.2879 and low of $0.261.

IGC Pharma Inc Share Price Chart

IGC Pharma Inc

us-stock
To Invest in {{usstockname}}
us-stock

IGC Pharma Inc Share Price Performance

$0.2862 0.0522(5.22%) IGC at 23 Mar 2026 01:37 PM Biotechnology
Lowest Today 0.261
Highest Today 0.2879
Today’s Open 0.2706
Prev. Close 0.272
52 Week High 0.50
52 Week Low 0.24
Day’s Range: Low 0.261 High 0.2879
52-Week Range: Low 0.24 High 0.50
1 day return -
1 Week return +1.25
1 month return +6.99
3 month return -6.19
6 month return -30.54
1 year return -9.19
3 year return -16.81
5 year return -84.82
10 year return -

IGC Pharma Inc Institutional Holdings

IGC Pharma Inc Market Status

Strong Buy: 2

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

IGC Pharma Inc Fundamentals

Market Cap 27.20 M

PB Ratio 3.1946

PE Ratio 0.0

Enterprise Value 24.87 M

Total Assets 8.75 M

Volume 766148

IGC Pharma Inc Company Financials

Annual Revenue FY25:1271000 1.3M, FY24:1345000 1.3M, FY23:911000 0.9M, FY22:397000 0.4M, FY21:898000 0.9M

Annual Profit FY25:619000 0.6M, FY24:733000 0.7M, FY23:442000 0.4M, FY22:194000 0.2M, FY21:113000 0.1M

Annual Net worth FY25:-7121000 -7.1M, FY24:-13000000 -13.0M, FY23:-11441000 -11.4M, FY22:-14604000 -14.6M, FY21:-8980000 -9.0M

Quarterly Revenue Q3/2025:191000 0.2M, Q2/2025:328000 0.3M, Q1/2025:330000 0.3M, Q4/2024:257000 0.3M, Q3/2024:412000 0.4M

Quarterly Profit Q3/2025:99000 0.1M, Q2/2025:154000 0.2M, Q1/2025:154000 0.2M, Q4/2024:104000 0.1M, Q3/2024:198000 0.2M

Quarterly Net worth Q3/2025:-1821000 -1.8M, Q2/2025:-1599000 -1.6M, Q1/2025:-1197000 -1.2M, Q4/2024:-1829000 -1.8M, Q3/2024:-1717000 -1.7M

About IGC Pharma Inc & investment objective

Company Information IGC Pharma, Inc., a clinical stage pharmaceutical company, develops novel therapeutic candidates for neuropsychiatric and neurodegenerative disorders, with a primary focus on Alzheimer's disease in the United States and Colombia. The company's lead product is IGC-AD1 that is in Phase II clinical trial for the treatment of agitation in dementia due to Alzheimer's. Its pre-clinical stage product candidate includes TGR-63 and IGC-M3 to treat Alzheimer's disease. In addition, the company develops MINT-AD, an AI-driven assistant for healthcare providers. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. IGC Pharma, Inc. was incorporated in 2005 and is headquartered in Potomac, Maryland.

Organisation Biotechnology

Employees 70

Industry Biotechnology

CEO Mr. Ram Mukunda

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

IGC Pharma Inc FAQs

What is the share price of IGC Pharma Inc today?

The current share price of IGC Pharma Inc is $0.2862.

Can I buy IGC Pharma Inc shares in India?

Yes, Indian investors can buy IGC Pharma Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy IGC Pharma Inc shares in India?

You can easily invest in IGC Pharma Inc shares from India by:

Can I buy fractional shares of IGC Pharma Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of IGC Pharma Inc?

IGC Pharma Inc has a market cap of $27.20 M.

In which sector does IGC Pharma Inc belong?

IGC Pharma Inc operates in the Biotechnology sector.

What documents are required to invest in IGC Pharma Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of IGC Pharma Inc?

The PE ratio of IGC Pharma Inc is N/A and the PB ratio is 3.19.